Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial.

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2019 01 01; 5(1):e183773.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Azepines
Breast Neoplasms
Disease Progression
Europe
Female
Humans
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Ovarian Neoplasms
Paclitaxel
Pyrimidines
Time Factors
United States

authors with profiles

SIQING FU
ROBERT COLEMAN